Life Extension Magazine June 2004
Are You Afraid of Terrorists?
By William Faloon
LE Magazine June 2004
|Are You Afraid of Terrorists?|
Preventing Cancer with Anti-Aging Therapies
Gene expression is the first step in determining the activity and decline of the body’s systems. The next step is the actions that genes have on proteins and other substances in the body. BioMarker is planning to conduct proteomic studies with specimens of tissue it preserved when conducting its previous gene chip experiments. Proteomic research will enable BioMarker scientists to trace the effects of changes in gene expression on physiologic changes in aging tissues, which will in turn allow the company to find out more about anti-aging and anti-disease mechanisms.
BioMarker is collaborating with scientists at the National Cancer Institute in the design of studies that will attempt to elucidate mechanisms that could lead to the development of new anti-aging and anticancer therapies.
A New Product to Make You Look Better Today
While MicroDermAbrasion is primitive technology compared to our genomic research, proceeds from the sale of this appearance-enhancing product help us meet the enormous costs of conducting gene expression chip studies on compounds that may enable us to slow and even reverse the aging process.
Today, almost 6,500 Americans will silently perish from cancer, heart attack, or one of the many other diseases of aging. You will not hear about this on the evening news. Instead, the media will cover stories relating to terrorism threats or isolated violent acts. Life Extension cannot do much about these problems, but we are dedicated to protecting the lives of Americans who die needlessly because of governmental ineptitude and neglect.
Every time you purchase a Life Extension product that provides you with immediate benefits, you also help fund lifesaving scientific research.
For longer life,
1. US National Center for Health Statistics, National Vital Statistics Report, 2003 March 14;51.Available at: www.cdc.gov/nchs.
2. Available at: http://www.cdc.gov/nchs/fastats/deaths.htm. Accessed March 25, 2004.
3. Available at: http://www.cancer.org/downloads/MED/Page6.pdf. Accessed March 25, 2004.
4. Available at: http://www.cancer.gov/newscenter/13mar02colorectal. Accessed March 25, 2004.
5. Available at: http://www.cancer.gov/newscenter/childtumors. Accessed March 25, 2004.
6. Available at: www.deathclock.com. Accessed March 25, 2004.
7. Available at: www.lef.org. Accessed March 25, 2004.
8. Available at: http://www.lef.org/magazine/mag2000/dec2000_awsi2.html. Accessed March 25, 2004.
9. Available at: www.drugs.com/erbitux.html. Accessed March 25, 2004.
10. Available at: http://www.lef.org/magazine/mag98/july98_awsi.html. Accessed March 25, 2004.
11. Available at: http://www.fda.gov/bbs/topics/NEWS/2004/NEW01027.html. Accessed March 25, 2004.
12. Available at: http://www.cancer.org/down loads/STT/CancerFacts&Figures 2002TM.pdf. Accessed March 25, 2004.
13. Available at: http://www.asco.org/ac/1,1003,_12-002489-00_18-002003-00_19- 00104122,00.asp. Accessed March 25, 2004.
14. Available at: http://www.seattleprostateinst.com/Vol17-02-04.pdf. Accessed March 25, 2004.
15. New cancer drugs. Wall Street Journal. January 26, 2004.
16. Higgs, R. The defense budget is bigger than you think. San Francisco Chronicle. January 18, 2004. Available at: http://www.independent.org/tii/news/040118Higgs.html. Accessed March 29, 2004.
17. Available at: http//www.nih.gov/news/fundingresearchareas.htm. Accessed March 25, 2004.
18. Mattison JA, Lane MA, Roth GS, Ingram DK. Calorie restriction in rhesus monkeys. Exp Gerontol. 2003 Jan-Feb;38(1-2):35-46.
19. Lane MA, Mattison J, Ingram DK, Roth GS. Caloric restriction and aging in primates: Relevance to humans and possible CR mimetics. Microsc Res Tech. 2002 Nov 15;59(4):335-8.
20. Weindruch R, Kayo T, Lee CK, Prolla TA. Gene expression profiling of aging using DNA microarrays. Mech Ageing Dev. 2002 Jan;123(2-3):177-93.
21. Roth GS, Ingram DK, Lane MA. Caloric restriction in primates and relevance to humans. Ann N Y Acad Sci. 2001 Apr;928:305-15.
22. Merker K, Stolzing A, Grune T. Proteolysis, caloric restriction and aging. Mech Ageing Dev. 2001 May 31;122(7):595-615.
23. Weindruch R. The retardation of aging by caloric restriction: studies in rodents and pri- mates. Toxicol Pathol. 1996 Nov- Dec;24(6):742-5.
24. Weindruch R, Walford RL, Fligiel S, Guthrie D. The retardation of aging in mice by dietary restriction: longevity, cancer, immu- nity and lifetime energy intake. J Nutr. 1986 Apr;116(4):641-54.
25. McCay CM, Crowell MF, Maynard LA. The effect of retarded growth upon the length of life span and upon the ultimate body size. Nutrition. 1989 May-Jun;5(3):155-71; discussion 172.
26. Flurkey K, Papaconstantinou J, Miller RA, Harrison D E. Life span extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6736-41.
27. Miller RA. Kleemeier award lecture: are there genes for aging? J Gerontol Biol Sci. 1999 Jul;54(7):B297-307.
28. Bartke A. Genetic models in the study of anterior pituitary hormones. In: Shire JGM, ed. Genetic Variation in Hormone Systems. CRC Press; 1979:113-26.
29. Bartke A, Wright JC, Mattison JA, Ingram DK, Miller RA, Roth GS. Extending the life span of long-lived mice. Nature. 2001 Nov 22:414(6862):412.
30. Tsuchiya T, Dhahbi JM, Cui X, Mote PL, Spindler SR. Additive regulation of hepatic gene expression by dwarfism and caloric restriction. Physiol Genomics. 2004 Mar 23. Available at: http://physiolgenomics.physiology.org/papbyrecent.shtml Accessed March 26, 2004.
31. Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science. 1999 Aug 27;285(5432):1390-3.
32. Dhahbi JM, Mote PL, Wingo J, et al. Caloric restriction alters the feeding response of key metabolic enzyme genes. Mech Ageing Dev. 2001 Jul 31;122(10):1033-48.
33. Dilman VM, Anisimov VN. Effect of treat- ment with phenformin, diphenylhydantoin or L-dopa on life span and tumour incidence in C3H/Sn mice. Gerontology. 1980;26(5):241-6.
34. Pace-Asciak CR, Hanh S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protec- tion against coronary heart disease. Clin Chim Acta. 1995 Mar 31; 235(2):207-19.
35. Cal C, Garban H, Jazirehi A, Yeh C, Mizutani Y, Bonavida B. Resveratrol and cancer: chemoprevention, apoptosis, and chemoimmunosensitizing activities. Curr Med Chem Anti-Canc Agents. 2003 Mar;3(2):77-93.
36. Gusman J, Malonne H, Atassi G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis. 2001 Aug;22(8):1111-7.
37. Lu R, Serrero G. Resveratrol, a natural product derived from grape, exhibits anti-estrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol. 1999 Jun;179(3):297-304.
38. Serrero G, Lu R. Effect of resveratrol on the expression of autocrine growth modulators in human breast cancer cells. Antioxid Redox Signal. 2001 Dec;3(6):969-79.
39. Mitchell SH, Zhu W, Young CY. Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate can- cer cells. Cancer Res. 1999 Dec 1;59(23):5892-5.
40. Narayanan BA, Narayanan NK, Stoner GD, Bullock BP. Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants. Life Sci. 2002 Mar 1;70(15):1821-39.
41. Ulsperger E, Hamilton G, Raderer M, et al. Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stim- ulation in response to carcinoma cell super- natants. Int J Oncol. 1999 Nov;15(5):955-9.
42. Lipkin M, Reddy B, Newmark H, Lamprecht SA. Dietary factors in human colorectal can- cer. Annu Rev Nutr. 1999;19:545-86.
43. Nakagawa H, Kiyozuka Y, Uemura Y, et al. Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stim- ulator. J Cancer Res Clin Oncol. 2001 Apr;127(4):258-64.
44. Floreani M, Napoli E, Quintieri L, Palatini P. Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity. Life Sci. 2003 May 2;72(24):2741-50.
45. Hsieh TC, Burfeind P, Laud K, et al. Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int J Oncol. 1999 Aug;15(2):245-52.
46. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer. 2001 Nov 30;85(11):1700-5.
47. Ding XZ, Adrian TE. Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Pancreas. 2002 Nov;25(4):71-6.
48. Yamasaki L, Bronson R, Williams BO, Dyson NJ, Harlow E, Jacks T. Loss of E2F- 1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nat Genet. 1998 Apr;18(4):360-4.
49. Roth GS, Ingram DK, Lane MA. Calorie restriction in primates: will it work and how will we know? J Am Geriatr Soc. 1999 Jul;47(7):896-903.
50. Grasl-Kraupp B, Bursch W, Ruttkay-Nedecky B, Wagner A, Lauer B, Schulte- Hermann R. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9995-9.
51. Weindruch R, Walford RL. Dietary restriction in mice beginning at 1 year of age: effect on life span and spontaneous cancer inci- dence. Science. 1982 Mar 12;215(4538):1415-8.
52. Kritchevsky D, Klurfeld DM. Influence of caloric intake on experimental carcinogene- sis: a review. Adv Exp Med Biol. 1986;206:55-68.
53. Albanes D. Caloric intake, body weight, and cancer: a review. Nutr Cancer. 1987;9(4):199-217.
54. Kritchevsky D. Caloric restriction and exper- imental mammary carcinogenesis. Breast Cancer Res Treat. 1997 Nov-Dec;46(2- 3):161-7.
55. Kritchevsky D. Caloric restriction and can- cer. J Nutr Sci Vitaminol (Tokyo). 2001 Feb;47(1):13-9.